{"title": "Medicines", "author": "EMA; COMM; DG; UNIT", "url": "https://www.ema.europa.eu/en/medicines", "hostname": "europa.eu", "description": "European Medicines Agency -", "sitename": "European Medicines Agency", "date": "2023-09-07", "cleaned_text": "European public assessment report (EPAR): Abasaglar (previously Last updated: 24/09/2021 - Human medicine European designation: Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human B cell maturation antigen with 4-1BB and CD3-zeta intracellular signalling domains designation: 20/04/2017, Positive, Last updated: 03/12/2021 - List item Human medicine European public assessment (EPAR): Abevmybevacizumab, Colorectal Post-authorisation, (PIP): Abilify, aripiprazoleDecision type: PM: decision on the application for agreed PIP Therapeutic area: Psychiatry PIP number: use, Pharmaceutical form(s): Tablet, Orodispersible tablet, Oral solution, Solution for injection Decision date: 26/10/2012, Last updated: 26/11/2012, Compliance check: V, 24/06/2016 - List item Human medicine European public assessment report (EPAR): Abilifyaripiprazole, Schizophrenia; Bipolar Disorder Authorised, Last updated: 08/04/2022 - List Human medicine European public assessment report (EPAR): Abilify Maintenaaripiprazole, Schizophrenia 17/07/2020, Initial authorisation, Last updated: 22/10/2020 - List item Human medicine European public assessment report (EPAR): Abiraterone updated: 05/05/2021 - List public assessment report (EPAR): Abiraterone updated: 08/03/2023 - Human medicine European public assessment report (EPAR): Abiraterone updated: 18/07/2023 - item Human medicine European public assessment report (EPAR): Ablavar (previously Vasovist)gadofosveset trisodium, Magnetic Resonance Angiography 03/10/2005, Revision: 10, Withdrawn, (PIP): Abraxane, paclitaxelDecision type: PM: decision on the application infusion date: 14/08/2018, Last updated: 19/12/2018, Compliance check: V, 21/09/2018 - List item Human medicine European public assessment report (EPAR): Abraxanepaclitaxel, Breast Neoplasms; opinion: vaccines, opinion date: 20/07/2023, Positive, Last updated: 21/07/2023 - List item Human medicine European public assessment report (EPAR): Abseamed (updated)epoetin alfa, Anemia; Kidney Failure, withdrawal: 17/12/2021, Initial authorisation, Last updated: 23/11/2022 - List item Human medicine European public assessment (EPAR): Accofilfilgrastim, Neutropenia updated: 24/07/2023 - item Human medicine European public assessment report (EPAR): Aclastazoledronic acid, Aclasta, zoledronic acidDecision type: PM: decision on the Last updated: 16/09/2021, Compliance check: V, 30/04/2020 - List item Human medicine European public assessment report (EPAR): Acompliarimonabant, Obesity Date of authorisation: 19/06/2006, Revision: 8, Withdrawn, Last updated: 30/01/2009 - List item Human medicine European public assessment report (EPAR): Acrescentmemantine hydrochloride, donepezil hydrochloride, Alzheimer Disease "}